CARBAMAZEPINE
- Product NDC
- 51655-017
- 11-digit product format
- 516550017
- Labeler code
- 51655
- Product ID
- 51655-017_68b0341d-59e4-43c1-a1c4-71b7907d6e3e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CARBAMAZEPINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Pharmaceuticals, LLC
- Application
- ANDA075948
- Marketing category
- ANDA
- Marketing start
- 2015-03-03
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-017 | CARBAMAZEPINE TABLET [NORTHWIND PHARMACEUTICALS, LLC] | 1 | Legacy NDC | 20150323_8e5df2e3-92fc-4865-97de-1da0a32c788d.zip |